This inventor holds 2 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Kyoto University, Megakaryon Corporation. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021-2024
Title: Unveiling the Innovations of Inventor Hiroshi Endo
Introduction:
Meet the brilliant mind behind groundbreaking innovations in Kyoto, Japan - Hiroshi Endo. With a keen focus on mesoderm induction methods, he has been at the forefront of cutting-edge research and development in the field of stem cell technology.
Latest Patents:
Hiroshi Endo's latest patent, "Mesoderm induction method having high blood cell differentiation capacity," revolutionizes the process of inducing mesoderm. By utilizing bone morphogenetic protein 4 (BMP4) or CHIR for at least 3 days, his method demonstrates remarkable efficiency and effectiveness in blood cell differentiation.
Career Highlights:
Having accumulated 1 patent to his name, Hiroshi Endo has made significant contributions to the field of biomedical research. His dedication to advancing mesoderm induction methods showcases his commitment to innovation and excellence in the scientific community.
Collaborations:
Throughout his career, Hiroshi Endo has collaborated with esteemed colleagues such as Koji Eto and Yukitaka Ito. His work with Kyoto University and Megakaryon Corporation has led to synergistic partnerships that have propelled forward the boundaries of stem cell research.
Conclusion:
In conclusion, Hiroshi Endo stands as a visionary inventor whose ingenuity and expertise have shaped the landscape of biomedical innovation. His pioneering work in mesoderm induction methods paves the way for a brighter future in stem cell technology, reaffirming his place among the trailblazers of our time.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile